Associated Papers
Analysis on GENIE reveals novel recurrent variants that affect molecular diagnosis of sizable number of cancer patients.
Koyama T et al.
Bmc Cancer, 2019
30709382 (PubMed )
Supplement: 12885_2019_5313_MOESM3_ESM.xlsx › supplementary_3_filtered
A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3.
Lahtela J et al.
Cell Cycle (georgetown, Tex.), 2013
Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms.
Lisabeth EM et al.
Biochemistry, 2012
Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.
Wood LD et al.
Human Mutation, 2006
Select a paper to view details